Company: JUNS
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010990
Chunk: 43

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 8
Chunk 43
---
In January 2024, the Company granted 180,000
stock options to a consultant with an exercise price of $1.33
per share and a grant date fair value of $190,560, of which 50% vested immediately with the remaining 50% being vested over a 12 month period.

As discussed in Note 3 – Related Party
Transactions, the Company also issued options for the forgiveness of accrued compensation.

The grant date fair value of stock options issued during the three-month period ended March 31, 2024 was determined using the Black-Scholes
Option Pricing Model. The significant inputs were as follows:

Schedule
of Grant Date Fair Value of Stock Options Issued

    Dividend Yield 
     0%
  
    Weighted average expected term (years) 
     6 
  
    Volatility 
     97.3%
  
    Risk-free rate 
     4.10%
  
    Weighted average exercise price 
    $1.33 

    18

JUPITER NEUROSCIENCES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2025

Note 6 – Stockholders’
Equity, continued

A summary of activity for the three months ended
March 31, 2025 is presented below:

Schedule of Stock Option
Activity

    Number of Options  
    Weighted Average Exercise Price  
    Weighted Average Contractual Term (Years)  
    Aggregate Intrinsic Value 
  
    Outstanding as of December 31, 2024  
     10,633,988  
     1.02  
     6.25  
    $102,921,147 
  
    Granted  
     -  
     -  

    Exercised  
     -  
     -  

    Forfeited  
     -  
     -  

    Outstanding as of March 31, 2025  
     10,633,988  
    $1.02  
     6.00  
    $405,750 
  
    Exercisable as of March 31, 2025  
     10,335,848  
    $1.01  
     5.93  
    $405,750 

The
following table summarizes information related to stock options outstanding as of